Yogeshchandra Amin
Internal Medicine · Fort Wayne, INNPI 1639154115
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $20.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$501
- GSK$474
- AbbVie$467
- Novo Nordisk$387
- Amgen$368
- Boehringer Ingelheim$278
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,084100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $501 |
| GSK | 18 | $474 |
| AbbVie(2 entities) | 31 | $467 |
| Novo Nordisk | 20 | $387 |
| Amgen(2 entities) | 15 | $368 |
| Boehringer Ingelheim | 13 | $278 |
| Lilly USA, LLC | 8 | $227 |
| Bayer | 8 | $197 |
| Novartis | 6 | $163 |
| Astellas Pharma US Inc | 5 | $101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $76 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Abbott | 4 | $66 |
| Nestle Healthcare Nutrition Inc. | 3 | $58 |
| Eisai Inc. | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $53 |
| Amarin Pharma, Inc. | 3 | $49 |
| Avanir Pharmaceuticals, Inc. | 3 | $44 |
| Pfizer | 3 | $41 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Radius Health, Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $27 |
| Sunovion Pharmaceuticals Inc. | 3 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Lifescan, Inc. | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Vivus LLC | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,084 in reported general payments places this provider in the 90th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 16 | $316 |
| Naproxen | 13 | $181 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Fort Wayne
- David IloFort Wayne$86K
- Anuradha KolliparaFort Wayne$30K
- Sumona KabirFort Wayne$28K
- Abhinav SinghGreenwood$733K
- Girish KunapareddyTerre Haute$329K
- Raj VuppalanchiIndianapolis$279K
- Joseph Arulandula Porte$251K
- Napoleon MamintaIndianapolis$116K
- Jennifer PaisleyLawrenceburg$112K
- Allon FriedmanIndianapolis$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.